Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) in Patients With Untreated Metastatic Colorectal Cancer

NCT00524706 is registered in ClinicalTrials.gov with Shizuoka Cancer Center as lead sponsor.

NCT NCT00524706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) in Patients With Untreated Metastatic Colorectal Cancer
Lead sponsor
Shizuoka Cancer Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2007
Completion date
April 30, 2011
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer